194 related articles for article (PubMed ID: 23867729)
1. Repeated intramuscular injections of nerve growth factor induced progressive muscle hyperalgesia, facilitated temporal summation, and expanded pain areas.
Hayashi K; Shiozawa S; Ozaki N; Mizumura K; Graven-Nielsen T
Pain; 2013 Nov; 154(11):2344-2352. PubMed ID: 23867729
[TBL] [Abstract][Full Text] [Related]
2. Repeated Injections of Low-Dose Nerve Growth Factor (NGF) in Healthy Humans Maintain Muscle Pain and Facilitate Ischemic Contraction-Evoked Pain.
Sørensen LB; Gazerani P; Sluka KA; Graven-Nielsen T
Pain Med; 2020 Dec; 21(12):3488-3498. PubMed ID: 33111942
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor-induced muscle hyperalgesia facilitates ischaemic contraction-evoked pain.
Sørensen LB; Gazerani P; Graven-Nielsen T
Eur J Pain; 2019 Nov; 23(10):1814-1825. PubMed ID: 31314952
[TBL] [Abstract][Full Text] [Related]
4. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans.
Andersen H; Arendt-Nielsen L; Svensson P; Danneskiold-Samsøe B; Graven-Nielsen T
Exp Brain Res; 2008 Nov; 191(3):371-82. PubMed ID: 18813917
[TBL] [Abstract][Full Text] [Related]
5. Temporal summation of pressure pain during muscle hyperalgesia evoked by nerve growth factor and eccentric contractions.
Nie H; Madeleine P; Arendt-Nielsen L; Graven-Nielsen T
Eur J Pain; 2009 Aug; 13(7):704-10. PubMed ID: 18710817
[TBL] [Abstract][Full Text] [Related]
6. The interaction between NGF-induced hyperalgesia and acid-provoked pain in the infrapatellar fat pad and tibialis anterior muscle of healthy volunteers.
Munkholm TK; Arendt-Nielsen L
Eur J Pain; 2017 Mar; 21(3):474-485. PubMed ID: 27634419
[TBL] [Abstract][Full Text] [Related]
7. Enlarged Areas of Pain and Pressure Hypersensitivityby Spatially Distributed Intramuscular Injections ofLow-Dose Nerve Growth Factor.
Sørensen LB; Boudreau SA; Gazerani P; Graven-Nielsen T
J Pain; 2019 May; 20(5):566-576. PubMed ID: 30513347
[TBL] [Abstract][Full Text] [Related]
8. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia.
Svensson P; Cairns BE; Wang K; Arendt-Nielsen L
Pain; 2003 Jul; 104(1-2):241-7. PubMed ID: 12855334
[TBL] [Abstract][Full Text] [Related]
9. Effects of NGF-induced muscle sensitization on proprioception and nociception.
Svensson P; Wang K; Arendt-Nielsen L; Cairns BE
Exp Brain Res; 2008 Jul; 189(1):1-10. PubMed ID: 18478213
[TBL] [Abstract][Full Text] [Related]
10. Movement Evoked Pain and Mechanical Hyperalgesia after Intramuscular Injection of Nerve Growth Factor: A Model of Sustained Elbow Pain.
Bergin MJ; Hirata R; Mista C; Christensen SW; Tucker K; Vicenzino B; Hodges P; Graven-Nielsen T
Pain Med; 2015 Nov; 16(11):2180-91. PubMed ID: 26178748
[TBL] [Abstract][Full Text] [Related]
11. Pressure algometry with a rotational fanning probe improves the detection of experimental muscle hyperalgesia.
Adnadjevic D; Graven-Nielsen T
Pain Med; 2015 Mar; 16(3):537-43. PubMed ID: 25529363
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women.
Svensson P; Castrillon E; Cairns BE
J Orofac Pain; 2008; 22(4):340-8. PubMed ID: 19090407
[TBL] [Abstract][Full Text] [Related]
13. Minocycline Prevents Muscular Pain Hypersensitivity and Cutaneous Allodynia Produced by Repeated Intramuscular Injections of Hypertonic Saline in Healthy Human Participants.
Samour MS; Nagi SS; Shortland PJ; Mahns DA
J Pain; 2017 Aug; 18(8):994-1005. PubMed ID: 28396046
[TBL] [Abstract][Full Text] [Related]
14. Muscular heat and mechanical pain sensitivity after lengthening contractions in humans and animals.
Queme F; Taguchi T; Mizumura K; Graven-Nielsen T
J Pain; 2013 Nov; 14(11):1425-36. PubMed ID: 24064034
[TBL] [Abstract][Full Text] [Related]
15. Effects of nerve growth factor experimentally-induced craniofacial muscle sensitization on referred pain frequency and number of headache days: A double-blind, randomized placebo-controlled study.
Exposto FG; Masuda M; Castrillon EE; Svensson P
Cephalalgia; 2018 Dec; 38(14):2006-2016. PubMed ID: 29528692
[TBL] [Abstract][Full Text] [Related]
16. Interaction between ultraviolet B-induced cutaneous hyperalgesia and nerve growth factor-induced muscle hyperalgesia.
Lo Vecchio S; Petersen LJ; Finocchietti S; Gazerani P; Christensen SW; Arendt-Nielsen L; Graven-Nielsen T
Eur J Pain; 2016 Aug; 20(7):1058-69. PubMed ID: 26709043
[TBL] [Abstract][Full Text] [Related]
17. Pressure-induced referred pain is expanded by persistent soreness.
Doménech-García V; Palsson TS; Herrero P; Graven-Nielsen T
Pain; 2016 May; 157(5):1164-1172. PubMed ID: 26808146
[TBL] [Abstract][Full Text] [Related]
18. Pain referral and regional deep tissue hyperalgesia in experimental human hip pain models.
Izumi M; Petersen KK; Arendt-Nielsen L; Graven-Nielsen T
Pain; 2014 Apr; 155(4):792-800. PubMed ID: 24447510
[TBL] [Abstract][Full Text] [Related]
19. Acidic saline-induced pain as a model for experimental masseter myalgia in healthy subjects.
Castrillon EE; Cairns B; List T; Svensson P; Ernberg M
Eur J Pain; 2013 Nov; 17(10):1438-46. PubMed ID: 23649906
[TBL] [Abstract][Full Text] [Related]
20. Experimental muscle hyperalgesia modulates sensorimotor cortical excitability, which is partially altered by unaccustomed exercise.
De Martino E; Zandalasini M; Schabrun S; Petrini L; Graven-Nielsen T
Pain; 2018 Dec; 159(12):2493-2502. PubMed ID: 30036294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
